您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览172

Over the past 2 decades, considerable progress has been made to further elucidate the complex pathogenesis of psoriasis, facilitating the development of a new armamentarium of more effective, targeted therapies. Despite these important advances, substantial deficits remain in our understanding of psoriasis and its treatment, necessitating further research in many areas. In the sixth section of the American Academy of Dermatology Psoriasis Guidelines of Care, gaps in research and care were identified. We discuss the most important gaps in research that currently exist and make suggestions for studies that should be performed to address these deficits. These encompass both basic science and clinical research studies, including large, prospective epidemiologic studies to determine the true prevalence and natural history of psoriasis; further molecular studies in patients with psoriatic and psoriatic arthritis to understand the function of psoriasis susceptibility genes and to identify novel therapeutic targets; studies to examine the role of environmental factors in the development of psoriasis; further investigation of the relationship between psoriasis and cardiometabolic disease; studies that examine the role of adjunctive therapies such as psychological interventions in appropriate patient groups; and finally, studies to identify biomarkers of disease severity and treatment response to optimize patient therapy.

作者:Caitriona, Ryan;Neil J, Korman;Joel M, Gelfand;Henry W, Lim;Craig A, Elmets;Steven R, Feldman;Alice B, Gottlieb;John Y M, Koo;Mark, Lebwohl;Craig L, Leonardi;Abby S, Van Voorhees;Reva, Bhushan;Alan, Menter

来源:Journal of the American Academy of Dermatology 2014 年 70卷 1期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:172
作者:
Caitriona, Ryan;Neil J, Korman;Joel M, Gelfand;Henry W, Lim;Craig A, Elmets;Steven R, Feldman;Alice B, Gottlieb;John Y M, Koo;Mark, Lebwohl;Craig L, Leonardi;Abby S, Van Voorhees;Reva, Bhushan;Alan, Menter
来源:
Journal of the American Academy of Dermatology 2014 年 70卷 1期
标签:
ACR American College of Rheumatology C-reactive protein CRP FDA Food and Drug Administration IFN IL MACE MI NB NIH National Institutes of Health PsA RA RCT TNF UV VEGF adjunctive therapies biologics cardiovascular disease comorbidities in psoriasis comparative studies disease severity environmental factors in the development of psoriasis future research studies interferon interleukin major adverse cardiovascular events methotrexate molecular studies in psoriatic and psoriatic arthritis myocardial infarction narrowband pathomechanisms and genetics of psoriasis phototherapy psoriasis psoriasis guidelines psoriasis treatment psoriatic arthritis psychological randomized controlled clinical trial research gaps rheumatoid arthritis therapeutic targets topical therapies tumor necrosis factor ultraviolet vascular endothelial growth factor
Over the past 2 decades, considerable progress has been made to further elucidate the complex pathogenesis of psoriasis, facilitating the development of a new armamentarium of more effective, targeted therapies. Despite these important advances, substantial deficits remain in our understanding of psoriasis and its treatment, necessitating further research in many areas. In the sixth section of the American Academy of Dermatology Psoriasis Guidelines of Care, gaps in research and care were identified. We discuss the most important gaps in research that currently exist and make suggestions for studies that should be performed to address these deficits. These encompass both basic science and clinical research studies, including large, prospective epidemiologic studies to determine the true prevalence and natural history of psoriasis; further molecular studies in patients with psoriatic and psoriatic arthritis to understand the function of psoriasis susceptibility genes and to identify novel therapeutic targets; studies to examine the role of environmental factors in the development of psoriasis; further investigation of the relationship between psoriasis and cardiometabolic disease; studies that examine the role of adjunctive therapies such as psychological interventions in appropriate patient groups; and finally, studies to identify biomarkers of disease severity and treatment response to optimize patient therapy.